Header Logo

Connection

Mignonette Du Plessis to South Africa

Back to Details
This is a "connection" page, showing publications Mignonette Du Plessis has written about South Africa.
Mignonette Du Plessis
Connection Strength
1,244
South Africa
  1. Corynebacterium diphtheriae Infections, South Africa, 2015-2023. Emerg Infect Dis. 2025 Mar; 31(3):417-426.
    View in: PubMed
    Score: 0,096
  2. Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children. Nat Commun. 2024 Sep 27; 15(1):8401.
    View in: PubMed
    Score: 0,093
  3. Molecular Characterization of Corynebacterium diphtheriae Outbreak Isolates, South Africa, March-June 2015. Emerg Infect Dis. 2017 08; 23(8):1308-1315.
    View in: PubMed
    Score: 0,057
  4. Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa. BMC Microbiol. 2017 Feb 21; 17(1):40.
    View in: PubMed
    Score: 0,055
  5. Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013. J Clin Microbiol. 2016 05; 54(5):1326-34.
    View in: PubMed
    Score: 0,052
  6. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect. 2014 May; 68(5):455-61.
    View in: PubMed
    Score: 0,044
  7. Population snapshot of invasive serogroup B meningococci in South Africa from 2005 to 2008. J Clin Microbiol. 2012 Aug; 50(8):2577-84.
    View in: PubMed
    Score: 0,040
  8. Invasive Neisseria meningitidis with decreased susceptibility to fluoroquinolones in South Africa, 2009. J Antimicrob Chemother. 2010 Oct; 65(10):2258-60.
    View in: PubMed
    Score: 0,035
  9. Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa. Int J Antimicrob Agents. 2008 Nov; 32 Suppl 1:S66-70.
    View in: PubMed
    Score: 0,031
  10. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J Clin Microbiol. 2008 Oct; 46(10):3208-14.
    View in: PubMed
    Score: 0,030
  11. Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019-2020. J Infect Dis. 2025 Apr 15; 231(4):e697-e707.
    View in: PubMed
    Score: 0,024
  12. A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa. J Infect Dis. 2025 Feb 20; 231(2):e328-e336.
    View in: PubMed
    Score: 0,024
  13. Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
    View in: PubMed
    Score: 0,024
  14. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
    View in: PubMed
    Score: 0,023
  15. Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol. 2024 Aug 14; 53(5).
    View in: PubMed
    Score: 0,023
  16. Geographical migration and fitness dynamics of Streptococcus pneumoniae. Nature. 2024 Jul; 631(8020):386-392.
    View in: PubMed
    Score: 0,023
  17. Risk Factors for Severe COVID-19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020-2022. Influenza Other Respir Viruses. 2024 May; 18(5):e13300.
    View in: PubMed
    Score: 0,023
  18. Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021. BMC Infect Dis. 2024 Mar 21; 24(1):336.
    View in: PubMed
    Score: 0,023
  19. Genomic characterization of Bordetella pertussis in South Africa, 2015-2019. Microb Genom. 2023 Dec; 9(12).
    View in: PubMed
    Score: 0,022
  20. Incidence and Transmission Dynamics of Bordetella pertussis Infection in Rural and Urban Communities, South Africa, 2016?2018. Emerg Infect Dis. 2023 02; 29(2):294-303.
    View in: PubMed
    Score: 0,021
  21. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat Commun. 2022 10 04; 13(1):5860.
    View in: PubMed
    Score: 0,020
  22. Pathogens detected using a syndromic molecular diagnostic platform in patients hospitalized with severe respiratory illness in South Africa in 2017. Int J Infect Dis. 2022 Sep; 122:389-397.
    View in: PubMed
    Score: 0,020
  23. A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV. Microb Genom. 2022 04; 8(4).
    View in: PubMed
    Score: 0,020
  24. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21. Lancet Infect Dis. 2022 Jun; 22(6):821-834.
    View in: PubMed
    Score: 0,020
  25. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 01 29; 399(10323):437-446.
    View in: PubMed
    Score: 0,019
  26. Epidemiology of Pertussis in Individuals of All Ages Hospitalized With Respiratory Illness in South Africa, January 2013-December 2018. Clin Infect Dis. 2021 08 02; 73(3):e745-e753.
    View in: PubMed
    Score: 0,019
  27. Human Immunodeficiency Virus Infection Is Associated With Increased Meningococcal Carriage Acquisition Among First-year Students in 2 South African Universities. Clin Infect Dis. 2021 07 01; 73(1):e28-e38.
    View in: PubMed
    Score: 0,019
  28. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
    View in: PubMed
    Score: 0,019
  29. Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. Microb Genom. 2020 05; 6(5).
    View in: PubMed
    Score: 0,017
  30. A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa. J Antimicrob Chemother. 2020 03 01; 75(3):512-520.
    View in: PubMed
    Score: 0,017
  31. Genomic differences among carriage and invasive nontypeable pneumococci circulating in South Africa. Microb Genom. 2019 10; 5(10).
    View in: PubMed
    Score: 0,017
  32. Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011-2016. Clin Infect Dis. 2019 09 05; 69(Suppl 2):S49-S57.
    View in: PubMed
    Score: 0,016
  33. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Clin Infect Dis. 2019 07 18; 69(3):495-504.
    View in: PubMed
    Score: 0,016
  34. The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013-2015. J Infect Dis. 2019 05 05; 219(11):1697-1704.
    View in: PubMed
    Score: 0,016
  35. Challenges and clinical relevance of molecular detection of Bordetella pertussis in South Africa. BMC Infect Dis. 2019 Mar 21; 19(1):276.
    View in: PubMed
    Score: 0,016
  36. Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018 03; 24(3):506-513.
    View in: PubMed
    Score: 0,015
  37. Invasive Disease Caused Simultaneously by Dual Serotypes of Streptococcus pneumoniae. J Clin Microbiol. 2018 01; 56(1).
    View in: PubMed
    Score: 0,015
  38. Enterovirus genotypes among patients with severe acute respiratory illness, influenza-like illness, and asymptomatic individuals in South Africa, 2012-2014. J Med Virol. 2017 10; 89(10):1759-1767.
    View in: PubMed
    Score: 0,014
  39. Genomic analysis of nontypeable pneumococci causing invasive pneumococcal disease in South Africa, 2003-2013. BMC Genomics. 2016 06 22; 17:470.
    View in: PubMed
    Score: 0,013
  40. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect. 2015 Nov; 71(5):544-52.
    View in: PubMed
    Score: 0,012
  41. Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One. 2014; 9(9):e107666.
    View in: PubMed
    Score: 0,012
  42. Challenges of using molecular serotyping for surveillance of pneumococcal disease. J Clin Microbiol. 2014 Sep; 52(9):3271-6.
    View in: PubMed
    Score: 0,011
  43. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
    View in: PubMed
    Score: 0,011
  44. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,011
  45. Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688. J Clin Microbiol. 2012 Nov; 50(11):3678-86.
    View in: PubMed
    Score: 0,010
  46. Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa. Vaccine. 2011 Mar 03; 29(11):2187-92.
    View in: PubMed
    Score: 0,009
  47. Single report of ß-lactam resistance in an invasive Haemophilus influenzae isolate from South Africa mediated by mutations in penicillin-binding protein 3, 2003-2008. Int J Antimicrob Agents. 2010 Nov; 36(5):480-2.
    View in: PubMed
    Score: 0,009
  48. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol. 2010 Jun; 48(6):2016-21.
    View in: PubMed
    Score: 0,009
  49. An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol. 2010 Jan; 48(1):184-91.
    View in: PubMed
    Score: 0,008
  50. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis. 2009 Aug 01; 200(3):379-89.
    View in: PubMed
    Score: 0,008
  51. Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa. J Clin Microbiol. 2009 May; 47(5):1319-24.
    View in: PubMed
    Score: 0,008
  52. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. Lancet. 2008 Mar 29; 371(9618):1108-13.
    View in: PubMed
    Score: 0,007
  53. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005. Int J Antimicrob Agents. 2008 Jul; 32(1):62-7.
    View in: PubMed
    Score: 0,007
  54. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis. 2008 Feb 01; 46(3):377-86.
    View in: PubMed
    Score: 0,007
  55. Meningococcal disease in South Africa, 1999-2002. Emerg Infect Dis. 2007 Feb; 13(2):273-81.
    View in: PubMed
    Score: 0,007
  56. Prevalence of DHPS polymorphisms associated with sulfa resistance in South African Pneumocystis jirovecii strains. J Eukaryot Microbiol. 2006; 53 Suppl 1:S110-1.
    View in: PubMed
    Score: 0,006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.